Article Details

Celltrion announces the positive top-line results of the global Phase III trial of Redavizumab (CT ...

Retrieved on: 2021-06-14 08:15:00

Tags for this article:

Click the tags to see associated articles and topics

Celltrion announces the positive top-line results of the global Phase III trial of Redavizumab (CT .... View article details on hiswai:

Excerpt

... Redavizumab (CT-P59), an anti-COVID-19 monoclonal antibody treatment ... By screening candidate antibodies and selecting those that show the ...

Article found on: quebecnewstribune.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up